Aktepe, O. H. Et Al. 2022. THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy. Irish Journal of Medical Science , vol.191, no.4 , 1561-1567.

Aktepe, O. H., Gundogdu, F., KÖSEMEHMETOĞLU, K., YETER, H. H., AKSOY, S., GÜVEN, D. C., ... Sahin, T. K.(2022). THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy. Irish Journal of Medical Science , vol.191, no.4, 1561-1567.

Aktepe, OKTAY Et Al. "THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy," Irish Journal of Medical Science , vol.191, no.4, 1561-1567, 2022

Aktepe, OKTAY H. Et Al. "THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy." Irish Journal of Medical Science , vol.191, no.4, pp.1561-1567, 2022

Aktepe, O. H. Et Al. (2022) . "THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy." Irish Journal of Medical Science , vol.191, no.4, pp.1561-1567.

@article{article, author={OKTAY HALİT AKTEPE Et Al. }, title={THSD7A expression: a novel immunohistochemical determinant in predicting overall survival of metastatic renal cell carcinoma treated with targeted therapy}, journal={Irish Journal of Medical Science}, year=2022, pages={1561-1567} }